Victoria V. Hargreaves
Papers
1
Total Citations
10
H-Index
1
About
Dr. Victoria V. Hargreaves is a leading researcher in in vitro toxicology, with a specialized focus on the assessment of combustible tobacco products and aerosol exposure systems. Her major contributions center on advancing methodologies for evaluating the cytotoxicity and genotoxicity of whole smoke, moving beyond traditional partitioned exposures like total particulate matter (TPM) and gas vapor phase (GVP). Her most cited work, "Development of a quantitative method for assessment of dose in in vitro evaluations using a VITROCELL® VC10® smoke exposure system," has garnered 10 citations, establishing a foundational protocol for more accurate, dose-controlled testing in tobacco product safety. This research is pivotal for regulatory science, offering a robust platform to simulate real-world inhalation scenarios. Dr. Hargreaves’ work is notable for bridging the gap between laboratory exposure systems and clinical relevance, enabling more precise risk assessment of novel tobacco products. Her achievements underscore her role in shaping modern toxicological standards, making her a key figure for students and researchers interested in inhalation toxicology and alternative testing methods.
Research Focus
Key Achievements
Top Papers
- 1